Amy Watts, O.D.
|Manager, Optometry and Contact Lens Service; Director, Optometric Residency Program|
|Specialty:||Optometry and Contact Lens Service|
Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
|Office Hours:||Monday, Wednesday, Thursday: 9:00 a.m. - 5:00 p.m.|
|OD||New England College of Optometry|
|Teaching Affiliation||Instructor in Ophthalmology, Harvard Medical School|
After graduating from the New England College of Optometry with her Doctorate of Optometry, Dr. Watts remained at the College and completed a Cornea and Contact Lens residency. During residency, she received training on anterior segment abnormalities and disease, fitting of contact lens to diseased and irregular corneas, and pre- and post-operative refractive surgery. She also received several awards, including the Mertz Contact Lens Residency Award (sponsored by the American Optometric Foundation), the Vistakon Contact Lens Award, and the New England College of Optometry Clinic Award. Following residency, she worked as an optometrist for the Boston Foundation for Sight and Eye Associates of New Mexico before joining Mass. Eye and Ear in 2010.
As Director of the Harvard Medical School Optometric Residency Training Program, which is accredited by the Accreditation Council on Optometric Education, Dr. Watts mentors one optometric resident per year. Additionally, she instructs ophthalmology residents in the fitting and care of difference contact lens modalities including soft, rigid gas permeable, hybrid, and scleral lenses for a variety of diagnoses.
Dr. Watts is a fellow of the American Academy of Optometry (FAAO), and a member of both the American Academy of Optometry (AAO) and the Contact Lens Association of Ophthalmologists (CLAO).
Routine contact lens fittings and specialty contact fitting for corneal disease, status post penetrating keratoplasty, keratoprosthesis, aphakic, pediatric, and trauma patients. Extensive experience and interest in fitting scleral lenses.
Fluid ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Rosenthal P, Croteau A. Eye and Contact Lens. 2005;31(3):130-134.